OPANA is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Endo Pharmaceuticals, Inc.. The primary component is Oxymorphone Hydrochloride.
| Product ID | 63481-613_14241cb2-6da3-45fe-8c75-f53717b57e13 | 
| NDC | 63481-613 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | OPANA | 
| Generic Name | Oxymorphone Hydrochloride | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2006-06-26 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA021611 | 
| Labeler Name | Endo Pharmaceuticals, Inc. | 
| Substance Name | OXYMORPHONE HYDROCHLORIDE | 
| Active Ingredient Strength | 10 mg/1 | 
| Pharm Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] | 
| DEA Schedule | CII | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2019-12-31 | 
| Marketing Start Date | 2006-06-26 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA021611 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2006-06-26 | 
| Marketing End Date | 2010-04-20 | 
| Marketing Category | NDA | 
| Application Number | NDA021611 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2006-06-26 | 
| Marketing End Date | 2020-04-30 | 
| Ingredient | Strength | 
|---|---|
| OXYMORPHONE HYDROCHLORIDE | 10 mg/1 | 
| SPL SET ID: | 10d4a5d9-9cb8-4dcf-9836-34c377990128 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 63481-612 | OPANA | OPANA | 
| 63481-613 | OPANA | OPANA | 
| 0054-0283 | Oxymorphone Hydrochloride | oxymorphone hydrochloride | 
| 0054-0284 | Oxymorphone Hydrochloride | oxymorphone hydrochloride | 
| 0115-1231 | Oxymorphone hydrochloride | Oxymorphone hydrochloride | 
| 0115-1232 | Oxymorphone hydrochloride | Oxymorphone hydrochloride | 
| 0115-1233 | Oxymorphone hydrochloride | Oxymorphone hydrochloride | 
| 0115-1234 | Oxymorphone hydrochloride | Oxymorphone hydrochloride | 
| 0115-1315 | Oxymorphone hydrochloride | Oxymorphone hydrochloride | 
| 0115-1316 | Oxymorphone hydrochloride | Oxymorphone hydrochloride | 
| 0115-1317 | Oxymorphone hydrochloride | Oxymorphone hydrochloride | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  OPANA  77471861  3553676 Dead/Cancelled | Endo Pharmaceuticals Inc. 2008-05-12 | 
|  OPANA  77471835  3585918 Dead/Cancelled | Endo Pharmaceuticals Inc. 2008-05-12 | 
|  OPANA  76665614  3252736 Dead/Cancelled | Endo Pharmaceuticals Inc. 2006-09-05 | 
|  OPANA  76478457  3060635 Live/Registered | Endo Pharmaceuticals Inc. 2002-12-20 |